3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoic acid;3-(5-methyl-1,2,4-oxadiazol-3-yl)-N-[2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propyl]benzamide;2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propan-1-amine
C48H44F6N8O5S2 — CID 158633814
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoic acid;3-(5-methyl-1,2,4-oxadiazol-3-yl)-N-[2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propyl]benzamide;2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propan-1-amine
3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoic acid;3-(5-methyl-1,2,4-oxadiazol-3-yl)-N-[2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propyl]benzamide;2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propan-1-amine (PubChem CID 158633814) has the molecular formula C48H44F6N8O5S2 and a molecular weight of 991.05 g/mol. Its IUPAC name is 3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoic acid;3-(5-methyl-1,2,4-oxadiazol-3-yl)-N-[2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propyl]benzamide;2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propan-1-amine.
Molecular Properties
| Compound Name | 3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoic acid;3-(5-methyl-1,2,4-oxadiazol-3-yl)-N-[2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propyl]benzamide;2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propan-1-amine |
|---|---|
| PubChem CID | 158633814 |
| Molecular Formula | C48H44F6N8O5S2 |
| Molecular Weight | 991.05 g/mol |
| Exact Mass | 990.28 |
| IUPAC Name | 3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoic acid;3-(5-methyl-1,2,4-oxadiazol-3-yl)-N-[2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propyl]benzamide;2-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]propan-1-amine |
| SMILES | CC(C)(CN)c1nc(-c2ccc(C(F)(F)F)cc2)cs1.Cc1nc(-c2cccc(C(=O)NCC(C)(C)c3nc(-c4ccc(C(F)(F)F)cc4)cs3)c2)no1.Cc1nc(-c2cccc(C(=O)O)c2)no1 |
| InChI | InChI=1S/C24H21F3N4O2S.C14H15F3N2S.C10H8N2O3/c1-14-29-20(31-33-14)16-5-4-6-17(11-16)21(32)28-13-23(2,3)22-30-19(12-34-22)15-7-9-18(10-8-15)24(25,26)27;1-13(2,8-18)12-19-11(7-20-12)9-3-5-10(6-4-9)14(15,16)17;1-6-11-9(12-15-6)7-3-2-4-8(5-7)10(13)14/h4-12H,13H2,1-3H3,(H,28,32);3-7H,8,18H2,1-2H3;2-5H,1H3,(H,13,14) |
| InChIKey | HZNAEPRPQVWHMN-UHFFFAOYSA-N |
| XLogP | 11.70 |
| TPSA | 196.04 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 69 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 991.05 |
| LogP ≤ 5 | 11.70 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158633814 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.